Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
2.240
-0.070 (-3.03%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $239.72 million as of February 21, 2025. Its market cap has increased by 196.69% in one year.
Market Cap
239.72M
Enterprise Value
68.53M
1-Year Change
196.69%
Ranking
Category
Stock Price
$2.24
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.50M to $239.72M, an increase of 11.76%. That is a compound annual growth rate of 1.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 160.00M | -9.66% |
| Dec 31, 2024 | 177.10M | 138.04% |
| Dec 29, 2023 | 74.40M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.98% |
| Dec 31, 2021 | 890.20M | 220.56% |
| Dec 31, 2020 | 277.70M | 255.12% |
| Dec 31, 2019 | 78.20M | -74.15% |
| Dec 31, 2018 | 302.50M | -60.22% |
| Dec 29, 2017 | 760.40M | 30.72% |
| Dec 30, 2016 | 581.70M | 7.13% |
| Dec 31, 2015 | 543.00M | 153.15% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |